Your browser doesn't support javascript.
loading
Targeted therapies for lupus nephritis: Current perspectives and future directions / 中华医学杂志(英文版)
Chinese Medical Journal ; (24): 34-43, 2024.
Artigo em Inglês | WPRIM | ID: wpr-1007736
ABSTRACT
Lupus nephritis (LN), a severe manifestation of systemic lupus erythematosus, poses a substantial risk of progression to end-stage renal disease, with increased mortality. Conventional therapy for LN relies on broad-spectrum immunosuppressants such as glucocorticoids, mycophenolate mofetil, and calcineurin inhibitors. Although therapeutic regimens have evolved over the years, they have inherent limitations, including non-specific targeting, substantial adverse effects, high relapse rates, and prolonged maintenance and remission courses. These drawbacks underscore the need for targeted therapeutic strategies for LN. Recent advancements in our understanding of LN pathogenesis have led to the identification of novel therapeutic targets and the emergence of biological agents and small-molecule inhibitors with improved specificity and reduced toxicity. This review provides an overview of the current evidence on targeted therapies for LN, elucidates the biological mechanisms of responses and failure, highlights the challenges ahead, and outlines strategies for subsequent clinical trials and integrated immunomodulatory approaches.
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Nefrite Lúpica / Inibidores de Calcineurina / Imunossupressores / Lúpus Eritematoso Sistêmico / Ácido Micofenólico Limite: Humanos Idioma: Inglês Revista: Chinese Medical Journal Ano de publicação: 2024 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Nefrite Lúpica / Inibidores de Calcineurina / Imunossupressores / Lúpus Eritematoso Sistêmico / Ácido Micofenólico Limite: Humanos Idioma: Inglês Revista: Chinese Medical Journal Ano de publicação: 2024 Tipo de documento: Artigo